Skip to main content
Clinical Trials/ACTRN12622000731796
ACTRN12622000731796
Recruiting
未知

A micro randomised trial (MRT) to test the effects of app-based motivational messages on physical activity and on heart rate via smartphone app compliance in patients with vulnerable coronary artery plaques.

The University of Sydney0 sites58 target enrollmentMay 20, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Sedentary lifestyle
Sponsor
The University of Sydney
Enrollment
58
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 20, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Intervention group participants from the LIVEPLUS study (ANZCTR registration: ACTRN12620001151921\).
  • 2\.Adults who can competently use a smartphone (running iOS or Android)
  • 3\.Presence of Low attenuation plaque on Coronary Computed Tomography Angiography
  • 4\.18\-80 years of age
  • 5\.BMI greater than or equal to 22\.0 kg/m2
  • 6\.Have no contraindications for the LIVEPLUS study
  • 7\.Able to give full informed consent

Exclusion Criteria

  • People from the Control group participants from the LIVEPLUS study (ANZCTR registration: ACTRN12620001151921\) will be excluded.
  • Additional exclusion criteria for the parent LIVEPLUS study are as follows:
  • 1\. History or clinical manifestation of any other significant metabolic, hematologic, pulmonary, cardio\- vascular, gastrointestinal, neurologic, immune, hepatic, renal, urologic disorders, or cancer that, in opinion of the investigator, would make the candidate ineligible for the study
  • 2\.Non\-MRI\-compatible implanted devices or implants
  • 3\.Estimated glomerular filtration rate (eGFR) less than 30mL/kg/1\.73m2
  • 4\.Inability to exercise via supine ergometer
  • 5\.Claustrophobia
  • 6\.Contraindications for adenosine: Sinus node disease (e.g. sick sinus syndrome, symptomatic sinus bradycardia), second\- or third\- degree heart blocks, unstable angina, bronchospasm (e.g. asthma), heart transplant recipient, history of seizure disorder
  • 7\.Contraindications for glyceryl trinitrate: Known nitrate hypersensitivity, severe anaemia, severe aortic or mitral stenosis, hypotension defined as resting systolic blood pressure equal to 89 mmHg.
  • 8\.Not suitable for CT coronary angiography due to contraindications

Outcomes

Primary Outcomes

Not specified

Similar Trials